UniProt ID | TGFI1_HUMAN | |
---|---|---|
UniProt AC | O43294 | |
Protein Name | Transforming growth factor beta-1-induced transcript 1 protein | |
Gene Name | TGFB1I1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 461 | |
Subcellular Localization |
Cell junction, focal adhesion. Nucleus matrix. Cytoplasm, cytoskeleton. Associated with the actin cytoskeleton colocalizes with stress fibers. |
|
Protein Description | Functions as a molecular adapter coordinating multiple protein-protein interactions at the focal adhesion complex and in the nucleus. Links various intracellular signaling modules to plasma membrane receptors and regulates the Wnt and TGFB signaling pathways. May also regulate SLC6A3 and SLC6A4 targeting to the plasma membrane hence regulating their activity. In the nucleus, functions as a nuclear receptor coactivator regulating glucocorticoid, androgen, mineralocorticoid and progesterone receptor transcriptional activity. May play a role in the processes of cell growth, proliferation, migration, differentiation and senescence. May have a zinc-dependent DNA-binding activity.. | |
Protein Sequence | MEDLDALLSDLETTTSHMPRSGAPKERPAEPLTPPPSYGHQPQTGSGESSGASGDKDHLYSTVCKPRSPKPAAPAAPPFSSSSGVLGTGLCELDRLLQELNATQFNITDEIMSQFPSSKVASGEQKEDQSEDKKRPSLPSSPSPGLPKASATSATLELDRLMASLSDFRVQNHLPASGPTQPPVVSSTNEGSPSPPEPTGKGSLDTMLGLLQSDLSRRGVPTQAKGLCGSCNKPIAGQVVTALGRAWHPEHFVCGGCSTALGGSSFFEKDGAPFCPECYFERFSPRCGFCNQPIRHKMVTALGTHWHPEHFCCVSCGEPFGDEGFHEREGRPYCRRDFLQLFAPRCQGCQGPILDNYISALSALWHPDCFVCRECFAPFSGGSFFEHEGRPLCENHFHARRGSLCATCGLPVTGRCVSALGRRFHPDHFTCTFCLRPLTKGSFQERAGKPYCQPCFLKLFG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEDLDALL -------CHHHHHHH | 9.02 | 22814378 | |
9 | Phosphorylation | EDLDALLSDLETTTS HHHHHHHHHHHHHHC | 40.79 | 22199227 | |
13 | Phosphorylation | ALLSDLETTTSHMPR HHHHHHHHHHCCCCC | 42.54 | 27732954 | |
14 | Phosphorylation | LLSDLETTTSHMPRS HHHHHHHHHCCCCCC | 19.54 | 27732954 | |
15 | Phosphorylation | LSDLETTTSHMPRSG HHHHHHHHCCCCCCC | 24.85 | 27732954 | |
16 (in isoform 2) | Phosphorylation | - | 18.72 | - | |
16 | Phosphorylation | SDLETTTSHMPRSGA HHHHHHHCCCCCCCC | 18.72 | 27732954 | |
21 | Phosphorylation | TTSHMPRSGAPKERP HHCCCCCCCCCCCCC | 33.17 | 29759185 | |
27 (in isoform 2) | Phosphorylation | - | 41.68 | - | |
32 (in isoform 2) | Phosphorylation | - | 9.39 | - | |
33 | Phosphorylation | ERPAEPLTPPPSYGH CCCCCCCCCCCCCCC | 44.45 | 28355574 | |
36 (in isoform 2) | Phosphorylation | - | 41.19 | - | |
37 | Phosphorylation | EPLTPPPSYGHQPQT CCCCCCCCCCCCCCC | 49.90 | 21955146 | |
38 | Phosphorylation | PLTPPPSYGHQPQTG CCCCCCCCCCCCCCC | 25.13 | 21955146 | |
44 | Phosphorylation | SYGHQPQTGSGESSG CCCCCCCCCCCCCCC | 39.74 | 21955146 | |
46 | Phosphorylation | GHQPQTGSGESSGAS CCCCCCCCCCCCCCC | 42.65 | 22199227 | |
49 | Phosphorylation | PQTGSGESSGASGDK CCCCCCCCCCCCCCC | 37.28 | 21955146 | |
50 | Phosphorylation | QTGSGESSGASGDKD CCCCCCCCCCCCCCC | 33.79 | 22199227 | |
51 (in isoform 2) | Phosphorylation | - | 32.80 | - | |
53 | Phosphorylation | SGESSGASGDKDHLY CCCCCCCCCCCCCEE | 51.56 | 25850435 | |
60 | Phosphorylation | SGDKDHLYSTVCKPR CCCCCCEEEEECCCC | 10.01 | 21945579 | |
61 | Phosphorylation | GDKDHLYSTVCKPRS CCCCCEEEEECCCCC | 22.26 | 21945579 | |
62 | Phosphorylation | DKDHLYSTVCKPRSP CCCCEEEEECCCCCC | 19.16 | 21945579 | |
65 (in isoform 2) | Phosphorylation | - | 38.85 | - | |
68 | Phosphorylation | STVCKPRSPKPAAPA EEECCCCCCCCCCCC | 45.89 | 29255136 | |
80 | Phosphorylation | APAAPPFSSSSGVLG CCCCCCCCCCCCCCC | 34.78 | 23663014 | |
81 | O-linked_Glycosylation | PAAPPFSSSSGVLGT CCCCCCCCCCCCCCC | 28.98 | 31492838 | |
81 | Phosphorylation | PAAPPFSSSSGVLGT CCCCCCCCCCCCCCC | 28.98 | 26657352 | |
82 | Phosphorylation | AAPPFSSSSGVLGTG CCCCCCCCCCCCCCH | 29.88 | 30266825 | |
83 | Phosphorylation | APPFSSSSGVLGTGL CCCCCCCCCCCCCHH | 34.56 | 23663014 | |
88 | Phosphorylation | SSSGVLGTGLCELDR CCCCCCCCHHHHHHH | 23.87 | 24117733 | |
102 (in isoform 2) | Ubiquitination | - | 18.53 | - | |
105 (in isoform 2) | Phosphorylation | - | 6.57 | - | |
109 (in isoform 2) | Ubiquitination | - | 39.36 | - | |
120 (in isoform 2) | Phosphorylation | - | 5.75 | - | |
122 | Phosphorylation | FPSSKVASGEQKEDQ CCCCCCCCCCCCCCC | 45.94 | 26657352 | |
123 (in isoform 2) | Phosphorylation | - | 31.45 | - | |
124 (in isoform 2) | Phosphorylation | - | 56.86 | - | |
126 (in isoform 2) | Phosphorylation | - | 59.98 | - | |
130 | Phosphorylation | GEQKEDQSEDKKRPS CCCCCCCCCCCCCCC | 61.15 | 26657352 | |
137 | Phosphorylation | SEDKKRPSLPSSPSP CCCCCCCCCCCCCCC | 57.87 | 29255136 | |
140 | Phosphorylation | KKRPSLPSSPSPGLP CCCCCCCCCCCCCCC | 61.24 | 29255136 | |
141 | Phosphorylation | KRPSLPSSPSPGLPK CCCCCCCCCCCCCCC | 27.70 | 29255136 | |
143 | Phosphorylation | PSLPSSPSPGLPKAS CCCCCCCCCCCCCCC | 33.28 | 25463755 | |
150 | Phosphorylation | SPGLPKASATSATLE CCCCCCCCCCCHHHH | 37.90 | 20873877 | |
152 | Phosphorylation | GLPKASATSATLELD CCCCCCCCCHHHHHH | 19.19 | 26657352 | |
153 | Phosphorylation | LPKASATSATLELDR CCCCCCCCHHHHHHH | 20.97 | 26657352 | |
155 | Phosphorylation | KASATSATLELDRLM CCCCCCHHHHHHHHH | 22.11 | 30242111 | |
164 | Phosphorylation | ELDRLMASLSDFRVQ HHHHHHHHHHHCCHH | 17.91 | 23911959 | |
166 | Phosphorylation | DRLMASLSDFRVQNH HHHHHHHHHCCHHHC | 32.01 | 23403867 | |
169 (in isoform 2) | Phosphorylation | - | 33.82 | - | |
170 (in isoform 2) | Phosphorylation | - | 7.25 | - | |
175 (in isoform 2) | Phosphorylation | - | 19.48 | - | |
177 | Phosphorylation | VQNHLPASGPTQPPV HHHCCCCCCCCCCCC | 43.28 | 18691976 | |
177 (in isoform 2) | Phosphorylation | - | 43.28 | - | |
180 | Phosphorylation | HLPASGPTQPPVVSS CCCCCCCCCCCCCCC | 58.18 | 28060719 | |
186 | Phosphorylation | PTQPPVVSSTNEGSP CCCCCCCCCCCCCCC | 31.51 | 22167270 | |
187 | Phosphorylation | TQPPVVSSTNEGSPS CCCCCCCCCCCCCCC | 24.52 | 22167270 | |
188 | Phosphorylation | QPPVVSSTNEGSPSP CCCCCCCCCCCCCCC | 29.77 | 22167270 | |
192 | Phosphorylation | VSSTNEGSPSPPEPT CCCCCCCCCCCCCCC | 18.94 | 29255136 | |
194 | Phosphorylation | STNEGSPSPPEPTGK CCCCCCCCCCCCCCC | 55.58 | 23401153 | |
199 | Phosphorylation | SPSPPEPTGKGSLDT CCCCCCCCCCCCHHH | 50.27 | 29255136 | |
203 | Phosphorylation | PEPTGKGSLDTMLGL CCCCCCCCHHHHHHH | 26.93 | 26657352 | |
207 | Sulfoxidation | GKGSLDTMLGLLQSD CCCCHHHHHHHHHHH | 2.52 | 30846556 | |
213 | Phosphorylation | TMLGLLQSDLSRRGV HHHHHHHHHHHHCCC | 40.25 | 28857561 | |
216 | Phosphorylation | GLLQSDLSRRGVPTQ HHHHHHHHHCCCCCC | 25.56 | 26657352 | |
284 | Phosphorylation | ECYFERFSPRCGFCN HHHHHCCCCCCCCCC | 20.04 | 28555341 | |
380 | Phosphorylation | RECFAPFSGGSFFEH CHHCCCCCCCCCCCC | 40.98 | 26657352 | |
383 | Phosphorylation | FAPFSGGSFFEHEGR CCCCCCCCCCCCCCC | 30.22 | 27251275 | |
386 (in isoform 2) | Phosphorylation | - | 38.73 | - | |
403 | Phosphorylation | HFHARRGSLCATCGL CCHHCCCCCCHHCCC | 20.61 | 26846344 | |
407 | Phosphorylation | RRGSLCATCGLPVTG CCCCCCHHCCCCCCC | 13.20 | 23927012 | |
413 | Phosphorylation | ATCGLPVTGRCVSAL HHCCCCCCCCHHHHH | 19.57 | 23927012 | |
418 | Phosphorylation | PVTGRCVSALGRRFH CCCCCHHHHHCCCCC | 22.77 | 24670416 | |
430 | Phosphorylation | RFHPDHFTCTFCLRP CCCCCCEEEEEECCC | 13.76 | 24719451 | |
449 | Ubiquitination | SFQERAGKPYCQPCF CHHHHCCCCCCCCHH | 31.65 | - | |
458 | Ubiquitination | YCQPCFLKLFG---- CCCCHHHHHCC---- | 22.86 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TGFI1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TGFI1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GCR_HUMAN | NR3C1 | physical | 10848625 | |
FAK2_HUMAN | PTK2B | physical | 9422762 | |
FAK2_HUMAN | PTK2B | physical | 11856738 | |
FAK1_HUMAN | PTK2 | physical | 11463817 | |
PAXI_HUMAN | PXN | physical | 11463817 | |
FAK1_HUMAN | PTK2 | physical | 9858471 | |
FAK2_HUMAN | PTK2B | physical | 9858471 | |
VINC_HUMAN | VCL | physical | 9858471 | |
GIT1_RAT | Git1 | physical | 12153727 | |
HSPB1_HUMAN | HSPB1 | physical | 11546764 | |
SMAD3_HUMAN | SMAD3 | physical | 15561701 | |
CBLC_HUMAN | CBLC | physical | 24831009 | |
HSPB1_HUMAN | HSPB1 | physical | 24831009 | |
HSPB2_HUMAN | HSPB2 | physical | 24831009 | |
SMAD3_HUMAN | SMAD3 | physical | 14755691 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68 AND SER-186, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33; SER-192 AND SER-194,AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND MASSSPECTROMETRY. | |
"Suppression of androgen receptor transactivation by Pyk2 viainteraction and phosphorylation of the ARA55 coregulator."; Wang X., Yang Y., Guo X., Sampson E.R., Hsu C.-L., Tsai M.-Y., Yeh S.,Wu G., Guo Y., Chang C.; J. Biol. Chem. 277:15426-15431(2002). Cited for: FUNCTION, INTERACTION WITH PTK2B/PYK2, AND PHOSPHORYLATION AT TYR-60BY FAK2. | |
"Phosphorylation of Hic-5 at tyrosine 60 by CAKbeta and Fyn."; Ishino M., Aoto H., Sasaski H., Suzuki R., Sasaki T.; FEBS Lett. 474:179-183(2000). Cited for: MUTAGENESIS OF TYR-60, PHOSPHORYLATION AT TYR-60, AND INTERACTION WITHCSK AND PTK2B/PYK2. |